Management of Progressive Radioiodine-Refractory Thyroid Carcinoma: Current Perspective

Patients with thyroid cancer (TC) usually have an excellent prognosis; however, 5–10% of them develop an advanced disease. The prognosis of this subgroup is still favourable if the lesions respond to radioactive iodine (RAI) treatment. Nearly two-thirds of advanced TC patients become RAI-refractory...

Descripción completa

Detalles Bibliográficos
Autores principales: Nervo, Alice, Retta, Francesca, Ragni, Alberto, Piovesan, Alessandro, Gallo, Marco, Arvat, Emanuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584766/
https://www.ncbi.nlm.nih.gov/pubmed/36275786
http://dx.doi.org/10.2147/CMAR.S340967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584766/
https://www.ncbi.nlm.nih.gov/pubmed/36275786
http://dx.doi.org/10.2147/CMAR.S340967

Ejemplares similares